SCHEMBL20460460

SCHEMBL20460460

Cc1cc(I)ccc1NC(=O)OCC(Cl)(Cl)Cl

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 4/20 0.52
▸ CYP1A2 P05177 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ ALDH1A1 P00352 3/20 0.42
▸ HTT P42858 1/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ LMNA P02545 2/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ NPC1 O15118 3/20 0.40
▸ RAB9A P51151 2/20 0.40
▸ OPRK1 P41145 1/20 0.39
▸ TAS1R3 Q7RTX0 3/20 0.39
▸ TAS1R1 Q7RTX1 3/20 0.39
▸ TAS1R2 Q8TE23 3/20 0.39
▸ NLRP3 Q96P20 1/20 0.38
▸ IDO1 P14902 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5962893 0.82 PTPRC (0.55) CYP1A2CYP2C9CYP2C19ALDH1A1KMT2A
SCHEMBL20460463 0.81 SMN1; SMN2 (0.50) SMN1; SMN2CYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL557858 0.77 SMN1; SMN2 (0.46) SMN1; SMN2ALDH1A1HTTKMT2AMEN1
SCHEMBL6197998 0.74 LMNA (0.49) SMN1; SMN2CYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL3219456 0.73 IDO1 (0.50) SMN1; SMN2CYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL18615673 0.73 ALDH1A1 (0.54) SMN1; SMN2CYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL4192284 0.72 ALDH1A1 (0.55) SMN1; SMN2CYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL20680256 0.71 MEN1 (0.54) SMN1; SMN2ALDH1A1HTTKMT2AMEN1
SCHEMBL24453237 0.70 ALDH1A1 (0.54) SMN1; SMN2CYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL1310816 0.70 ABCC9 (0.44) SMN1; SMN2CYP1A2CYP2C9CYP2C19KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10550073-B2 Benzamide derivative CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD. (CN) 2020-02-04 — — US disclosed
EP-3357916-A1 BENZAMIDE DERIVATIVE CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. (CN) 2018-08-08 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10550073-B2 Benzamide derivative CYP3A5, ABCB1, CYP2D6 SMN1; SMN2 2610/4885CYP1A2 20/4885CYP2C9 36/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback